Abib PDRN Retinal Eye Patch Review: Why the Two Named Actives Sit at the Bottom of the Label

Abib's PDRN Retinal Eye Patch is a jar of 60 single-use hydrogel patches in a textured pink jelly, lifted out with a spatula and worn under the eye or anywhere else on the face for 15 to 30 minutes. The format carries a real advantage over cream: occlusion. A hydrogel holds water against skin that is ten times thinner than the rest of the face, and the cooling effect is immediate regardless of what actives are in it.

The commercial story is PDRN and retinal, printed in the product name and repeated across every image. At $16.10 for 60 patches — 27 cents a pair — the value proposition is frequency rather than potency, and the formula backs that up: it is a glycerin-and-niacinamide hydrogel with a gum matrix, and the two headline actives sit at the very end of the ingredient list.

The three primary listing images, shown in carousel order. No buyer-uploaded photography accompanies this capture, so the gallery is the listing set only.

Individual review text was not rendered on this capture. The aggregate rating, the five-bucket histogram and the retailer's own aspect summary were all present, but no review card came back across the desktop, mobile and alternate-context passes. Nothing here quotes a review, and none was reconstructed.

Amazon's own aspect summary

Customers find these eye patches effective and moisturizing, noting they hydrate the skin around the eyes and stay firmly in place without slipping. They appreciate the gentle, smooth texture, brightening effect, and soothing properties, and consider them worth the money. Regarding residue, while some customers report their under-eye area looks smoother, others mention the patches leave a residue on their skin.

Mentions are counted by the retailer's own summariser across the review corpus; they are not a sample this report drew. An aspect at or near 50% is a split verdict, not a negative one.

This is a 39-position formula, and the first thing worth saying about it is positional: sodium DNA is at 31 and retinal is at 39 — the last slot in the list. Both sit behind the gum system, the pearlising agent, both colorants and the silica. In a 39-item INCI that is not ambiguous. Whatever the patches do, it is not being done by the two ingredients on the label. What is doing the work is a conventional hydrogel: water, glycerin, niacinamide at position 3, four gums, allantoin, panthenol and a little caffeine. The second thing worth saying is that none of it carries a safety score, because the community database has no entry for this product and no rating here was borrowed from a neighbouring one.

What's inside

Composition by role

The community ingredient database holds no entry for this patch, so no ingredient carries a safety score here and a safety-band count cannot be produced. The table instead groups all 39 positions by what they do, which is the only classification the list itself fully supports. Risk is handled in the grades chart below, from the ratings that are published for this product.

These are the comedogenic and irritancy grades from the consumer-claim database. Twelve of 39 positions carry a figure on either axis; the large 'Not rated' column is coverage, not cleanliness. A patch is also a different exposure: everything here sits on skin for 20-30 minutes and then comes off, so an ingredient's grade carries less weight than it would in a leave-on cream.

Key ingredient groups

What the formula signals as concerns

• May Trigger Acne — Can clog pores or trigger breakouts.
• May Worsen Oily Skin — May increase shine or excess oil.
• May Worsen Rosacea — Can trigger flare-ups in rosacea-prone skin.

Benefit map

Complete ingredient table

Position follows the current INCI order on the pack. Safety, acne and irritant columns come from the community ingredient database; comedogenic and irritancy columns come from the consumer-claim database. Both sets are reproduced as published, including their disagreements.

Coverage, stated plainly: zero of 39 positions carry a community safety score, and 12 of 39 carry a published comedogenic or irritancy grade. The remaining grades simply do not exist in either source, and no figure was inferred to fill them. The one classification that needs no rating at all — where an ingredient sits in the list — is reproduced in full above and is the most decision-relevant evidence in this section.

Price history as recorded by the public tracker

Movement over the monitored window

The tracker publishes turning points, not a continuous daily series, so the line below joins the dated observations it actually records. Gaps are real — the source records no intermediate value between them.

Method and limits

• Price, rank, rating, histogram and bullet copy were read from the US product page with a New York 10001 delivery context and native USD pricing; nothing was converted or estimated.
• Price history turning points were read from a public Amazon price tracker on the same date. Only the third-party lane holds data — Amazon has never held this buy box in the monitored window — and that is reported as an empty row, not as a gap in collection.
• The ingredient list was transcribed from the manufacturer's published panel and validated against two independent retailer copies; all three agree position for position, which is what makes the positional reading in Section 04 safe to state.
• No safety score exists for this formula in the community ingredient database. The two near-miss Abib entries were documented and excluded rather than used as a proxy.
• No buyer photography and no individual review text were available on this capture. Both gaps are stated where they occur.

Confidence by block

Compiled 2026-11-01. Prices, ranks and review counts move between captures; every figure here is a dated snapshot, not a standing quote.